Their extensive study suggested that FHR-4 may play a prominent role in complement dysregulation in AMD by competing with FH for component C3b binding, while accumulating in the choriocapillaris, Bruch’s membrane and drusen. This evidence concerns the gene C3 and age-related macular degeneration.